Agenda:
- An analyst’s view of the biotech market
- Geir Hiller Holom, Senior Equity Analyst at DNB Markets
- Targovax Business Overview
- Erik Digman Wiklund, CEO of Targovax
- Circular RNA (circRNA) – the new frontier in RNA therapeutics discovered in Scandinavia
- Thomas Hansen, VP Research at Targovax
There will be an informal Q&A and serving of food from 17:45.
Lubor Gaal, CFO og Andreas Storsve, VP Business Development, will also be present.
Registration by Monday 26 September at 12:00 to renate.birkeli@targovax.com